SIS
IMNM icon

Sound Income Strategies’s Immunome IMNM Stock Holding History

Sound Income Strategies’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-212
Closed -$4.76K – 1397
2026
Q1 		$4.76K Buy
+212
New +$4.72K ﹤0.01% 1846

Other funds holding IMNM

NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
MUAMU
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $215M AUM 47.21% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
BIM
Baldwin Investment Management West Conshohocken, Pennsylvania $1.03B AUM 22.29% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Sound Income Strategies's IMNM Position: Q2 2026 in Review

Sound Income Strategies sold out of Immunome (IMNM) in Q2 2026, closing a stake of 212 shares — an estimated $4.76K sold.

Sound Income Strategies first reported a position in IMNM in Q1 2026 and held it in 1 quarter. The position peaked at $4.76K in Q1 2026. 23 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Sound Income Strategies reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 212 Immunome shares in Q2 2026, an estimated $4.76K.
  • Sound Income Strategies first reported a position in Immunome in Q1 2026 and held it in 1 quarter.
  • Sound Income Strategies's Immunome position peaked at $4.76K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.